Autopsy report · NCT03300505

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

“Cancelled by the sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months before it started.
• Ran for about 3 years 8 months before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 2 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Michigan Rogel Cancer Center

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

ARRx; Enzalutamide

Participants

9

Sites

2

Countries

United States

Trials that died the same way

• TCR Alpha/Beta and CD19-deplete Haplo-HSCT
  “Cancelled by Sponsor” (99% match in meaning)
• Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome
  “Stopped by the sponsor” (81% match in meaning)
• Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC
  “stopped by sponsor” (79% match in meaning)
• Patient Perception of MultiPulse Therapy™ (MPT™)
  “Sponsor ceased operations” (75% match in meaning)
• Magnetic Muscle Stimulation of Abdominal Muscle
  “Sponsor Discontinued due to business decision.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.